News & Industry Updates

Press Releases Jun 01, 2023

ReAlta Life Sciences Announces Proof of Mechanism Data from the Phase 1b...

Norfolk, VA, June 1, 2023 – ReAlta Life Sciences (“ReAlta”), Inc., a company addressing life-threatening rare diseases through harnessing the...

Read More
Press Releases Mar 30, 2023

ReAlta Life Sciences Announces Poster Presentation at the American Thoracic Society 2023...

Presenting proof-of-mechanism clinical trial data in healthy volunteers of RLS-0071, the Company’s dual action complement inhibitor and innate anti-inflammatory product...

Read More